Edwards Lifesciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Edwards Lifesciences (NYSE: EW), the global leader in structural heart innovation, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025. Bernard Zovighian, CEO, will present at 11:15 a.m. PT, accompanied by CFO Scott Ullem.
The presentation will be accessible through a live webcast on the company's investor relations website at http://ir.edwards.com/, with an archived version available later the same day. Edwards Lifesciences focuses on developing breakthrough technologies and maintaining partnerships with healthcare stakeholders to deliver life-changing innovations to patients in need.
Edwards Lifesciences (NYSE: EW), leader globale nell'innovazione cardiaca strutturale, ha annunciato la sua partecipazione alla 43a Conferenza Sanitaria Annuale J.P. Morgan che si terrà martedì 14 gennaio 2025. Bernard Zovighian, CEO, presenterà alle 11:15 PT, accompagnato dal CFO Scott Ullem.
La presentazione sarà accessibile tramite una diretta web sul sito web per gli investitori della società all'indirizzo http://ir.edwards.com/, con una versione archiviata disponibile più tardi lo stesso giorno. Edwards Lifesciences si concentra sullo sviluppo di tecnologie innovative e sul mantenimento di partnership con i protagonisti del settore sanitario per fornire innovazioni che cambiano la vita ai pazienti bisognosi.
Edwards Lifesciences (NYSE: EW), líder global en innovación en el corazón estructural, ha anunciado su participación en la 43ª Conferencia Anual de Salud de J.P. Morgan el martes 14 de enero de 2025. Bernard Zovighian, CEO, presentará a las 11:15 a.m. PT, acompañado por el CFO Scott Ullem.
La presentación será accesible a través de una transmisión en vivo en el sitio web de relaciones con inversores de la empresa en http://ir.edwards.com/, con una versión archivada disponible más tarde el mismo día. Edwards Lifesciences se centra en desarrollar tecnologías innovadoras y mantener asociaciones con los interesados en el cuidado de la salud para ofrecer innovaciones que cambian la vida a los pacientes necesitados.
에드워즈 라이프사이언스(NYSE: EW)는 구조적 심장 혁신의 세계적인 리더로서 제43회 JP모건 헬스케어 컨퍼런스에 2025년 1월 14일 화요일에 참여한다고 발표했습니다. 버나드 조비기안 CEO가 오전 11시 15분 PT에 스콧 윌렘 CFO와 함께 발표할 예정입니다.
발표는 회사의 투자자 관계 웹사이트(http://ir.edwards.com/)를 통해 실시간 웹캐스트로 접속할 수 있으며, 같은 날 이후에 아카이브 버전도 제공될 예정입니다. 에드워즈 라이프사이언스는 획기적인 기술 개발과 헬스케어 이해관계자와의 파트너십 유지를 통해 필요한 환자에게 삶을 변화시키는 혁신을 제공하는 데 집중하고 있습니다.
Edwards Lifesciences (NYSE: EW), leader mondial en innovation cardiaque structurelle, a annoncé sa participation à la 43e Conférence Annuelle J.P. Morgan sur la Santé le mardi 14 janvier 2025. Bernard Zovighian, PDG, présentera à 11h15 PT, accompagné du CFO Scott Ullem.
La présentation sera accessible via un webinaire en direct sur le site web des relations investisseurs de l'entreprise à l'adresse http://ir.edwards.com/, avec une version archivée disponible plus tard dans la journée. Edwards Lifesciences se concentre sur le développement de technologies révolutionnaires et le maintien de partenariats avec les acteurs de la santé afin de fournir des innovations qui changent la vie aux patients dans le besoin.
Edwards Lifesciences (NYSE: EW), der globale Marktführer in der strukturellen Herzinnovation, hat seine Teilnahme an der 43. J.P. Morgan Healthcare Conference am Dienstag, den 14. Januar 2025, angekündigt. Bernard Zovighian, CEO, wird um 11:15 Uhr PT präsentieren, begleitet von CFO Scott Ullem.
Die Präsentation wird über einen Live-Stream auf der Investor-Relations-Website des Unternehmens unter http://ir.edwards.com/ zugänglich sein, wobei eine archivierte Version später am selben Tag verfügbar sein wird. Edwards Lifesciences konzentriert sich auf die Entwicklung bahnbrechender Technologien und die Aufrechterhaltung von Partnerschaften mit Akteuren im Gesundheitswesen, um lebensverändernde Innovationen für bedürftige Patienten bereitzustellen.
- None.
- None.
Bernard Zovighian, chief executive officer, is scheduled to present at 11:15 a.m. PT. Scott Ullem, chief financial officer, will also participate in the conference. A live webcast of the presentation will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com/, with an archived version accessible later the same day.
About Edwards Lifesciences
Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. Discover more at www.edwards.com and follow us on LinkedIn, Facebook, Instagram and YouTube.
Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250107783243/en/
Media Contact: Amy Hytowitz, 949-250-5070
Investor Contact: Mark Wilterding, 949-250-6826
Source: Edwards Lifesciences Corporation
FAQ
When will Edwards Lifesciences (EW) present at the J.P. Morgan Healthcare Conference 2025?
How can investors watch Edwards Lifesciences' (EW) J.P. Morgan Healthcare Conference presentation?
Who will represent Edwards Lifesciences (EW) at the 2025 J.P. Morgan Healthcare Conference?
What is Edwards Lifesciences' (EW) main business focus according to the announcement?
